| 6PJ2: reference: Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors., Matthew AN, Zephyr J, Nageswara Rao D, Henes M, Kamran W, Kosovrasti K, Hedger AK, Lockbaum GJ, Timm J, Ali A, Kurt Yilmaz N, Schiffer CA, mBio. 2020 Mar 31;11(2). pii: mBio.00172-20. doi: 10.1128/mBio.00172-20. PMID: 32234812 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).